Danaher | DHR - Ebit

Aktienkurs
177.25
Täglich Wechseln
-1.32 -0.74%
Monatlich
-5.29%
Jährlich
-10.09%
Q2 Prognose
173.46




Ebit Veränderung Datum
Abbott USD 1.85B 684M 2026-03
Agilent USD 353M 90M 2025-12
Align Technology USD 224.71M 40.06M 2025-12
Becton, Dickinson and Co. USD 663M 163M 2025-12
Bio Techne USD 54.46M 6.8M 2025-12
Bio-Rad Laboratories USD -418.8M 845.4M 2025-09
Boston Scientific USD 1.24B 203M 2025-12
Bruker USD 76.3M 7.6M 2025-12
Charles River Laboratories USD 75.82M 57.98M 2025-12
Danaher USD 1.34B 158M 2026-03
Dentsply International USD 538M 26M 2025-12
Edwards Lifesciences USD 514.7M 144.4M 2026-03
ESCO Technologies USD 38.39M 26.31M 2025-12
Fortive USD 225.5M 821.7M 2025-12
Henry Schein USD 186M 12M 2025-12
Illumina USD 256M 6M 2025-12
Intuitive Surgical USD 859.7M 5.6M 2026-03
IQVIA Holdings USD 2.68B 2.1B 2025-12
Keysight Technologies USD 337M 143M 2025-12
Laboratory Of America USD 382M 11M 2025-12
Medtronic USD 1.74B 40M 2025-12
Mettler Toledo International USD 351.93M 57.73M 2025-12
Myriad Genetics USD -3M 20.3M 2025-12
OraSure Technologies USD -13.59M 2.13M 2025-12
Quest Diagnostics USD 399M 13M 2026-03
Quidel USD -37.3M 82.5M 2025-12
Repligen USD 19.97M 3.16M 2025-12
Revvity USD 145.83M 47.49M 2025-12
Roper Industries USD 569.6M 18.7M 2026-03
Stryker USD 1.97B 609M 2025-12
Thermo Fisher Scientific USD 1.91B 389M 2026-03
Waters USD 270.52M 78.4M 2025-12
Zimmer Biomet Holdings USD 302.9M 35.4M 2025-12